Quantum Biopharma (QNTM) Return on Assets (2024 - 2026)

Quantum Biopharma (QNTM) has 3 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.

• Quarterly Return on Assets rose 1.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (up 1.0% YoY) and the FY2025 annual result came in at 0.01%, changed N/A from the prior year.
• Return on Assets advanced to 0.01% in Q1 2026 per QNTM's latest filing, from 0.01% in the prior quarter.
• The five-year high for Return on Assets was 0.01% in Q1 2026, with the low at 0.0% in Q4 2024.
• Average Return on Assets over 3 years is 0.0%, with a median of 0.01% recorded in 2025.
• The widest YoY moves for Return on Assets: up 1 bps in 2025, down 1 bps in 2025.
• Quantum Biopharma's Return on Assets stood at 0.0% in 2024, then jumped by 535 bps to 0.01% in 2025, then jumped by 65 bps to 0.01% in 2026.
• Business Quant data shows QNTM's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.